Optimizing sustained use of sedation in mechanically ventilated patients: Focus on safety

Current Drug Safety

Volumn 5, Issue 1, 2010, Pages 6-12

  Arnold, Heather M ^a   Hollands, James M ^a   SkrupkY , Lee P ^a   Micek, Scott T ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

Delirium; Dexmedetomidine; Lorazepam; Midazolam; Patient safety; Propofol; Sedation

Indexed keywords

DEXMEDETOMIDINE; DIAZEPAM; FENTANYL; LORAZEPAM; MIDAZOLAM; PROPOFOL;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ARTIFICIAL VENTILATION; ASYSTOLE; BRADYCARDIA; CLINICAL FEATURE; CLINICAL TRIAL; COMA; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DRUG ACCUMULATION; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG ELIMINATION; DRUG FATALITY; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEVER; FOOD AND DRUG ADMINISTRATION; HEART ARREST; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART BUNDLE BRANCH BLOCK; HEPATOMEGALY; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERLIPIDEMIA; HYPEROSMOLARITY; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOTENSION; LACTIC ACIDOSIS; LOADING DRUG DOSE; METABOLIC ACIDOSIS; PAIN; PATIENT ASSESSMENT; PATIENT MONITORING; PATIENT SAFETY; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; RHABDOMYOLYSIS; SECONDARY INFECTION; SEDATION; SHOCK; SINUS ARREST; SINUS BRADYCARDIA; TACHYCARDIA; VENTILATED PATIENT;

BRADYCARDIA; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; HUMANS; HYPERTRIGLYCERIDEMIA; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; PROPOFOL; RESPIRATION, ARTIFICIAL;

EID: 77950790017     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488610789869102     Document Type: Review

References (52)

1. Hansen-Flaschen JH, Brazinsky S, Basile C, Lanken PN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. A national survey. JAMA 1991; 266: 2870-2875
2. Watling SM, Dasta JF, Seidl EC. Sedatives, analgesics, and paralytics in the ICU. Ann Pharmacother 1997; 31: 148-153
3. Payen JF, Chanques G, Mantz J, et al. Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology 2007; 106: 687-695
4. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30: 119-141 (Pubitemid 34112188)
5. Barnes BJ, Gerst C, Smith JR, et al. Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation. Pharmacotherapy 2006; 26: 23-33.
6. Yahwak JA, Riker RR, Fraser GL, et al. Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity. Pharmacotherapy 2008; 28: 984-991
7. Pohlman AS, Simpson KP, Hall JB. Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study. Crit Care Med 1994; 22: 1241-1247
8. Cernaianu AC, DelRossi AJ, Flum DR, et al. Lorazepam and midazolam in the intensive care unit: a randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy and cost. Crit Care Med 1996; 26: 222-228
9. Swart EL, Strack van Schijndel RJM, van Loenen AC, et al. Continuous infusion of lorazepam versus midazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effective. Crit Care Med 1999; 27: 1461-1465
10. McCollam JW, O'Neil MG, Norcross ED, et al. Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison. Crit Care Med 1999; 27: 2454-2458
11. Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med 1999; 27: 1325-1329
12. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation- Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002; 166: 1338-1344
13. Ely EW, Truman B, Shintani A, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 2003; 289: 2983-2991
14. Diprivan [package insert]. Wilmington DE.: AstraZenca Pharmaceuticals 2005.
15. Knibbe CA, Zuideveld KP, DeJongh J, et al. Population pharmacokinetic and pharmcodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%. Clin Pharmacol Ther 2002; 72: 670-684
16. Devlin JW, Lau AK, Tanios MA. Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors. Pharmacotherapy 2005; 25: 1348-1352
17. Fodale V, La Monaca E. Propofol infusion syndrome: an overview of a perplexing disease. Drug Saf 2008; 31: 293-303.
18. Parke TJ, Stevens JE, Rice AS, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992; 305: 613-616
19. Marinella MA. Lactic acidosis associated with propofol [letter]. Chest 1996; 109: 292.
20. Bray RJ. Propofol infusion syndrome in children. Paediatr Anaesth 1998; 8: 491-499
21. Laquay N, Pouard P, Silicani MA, et al. Early stages of propofol infusion syndrome in paediatric cardiac surgery: two cases in adolescent girls. Br J Anaesth 2008; 101: 880-881
22. Robinson JD, Melman Y, Walsh EP. Cardiac conduction disturbances and ventricular tachycardia after prolonged propofol infusion in an infant. Pacing Clin Electrophysiol 2008 ; 31: 1070-1073
23. Ilyas MI, Balacumararaswami L, Palin C, et al. Propofol infusion syndrome in adult cardiac surgery. Ann Thorac Surg 2009; 87: 1-3.
24. Smith H, Sinson G, Varelas P. Vasopressors and propofol infusion syndrome in severe head trauma. Neurocrit Care 2009; 10: 166-172
25. Corbett SM, Montoya ID, Moore FA. Propofol-related infusion syndrome in intensive care patients. Pharmacotherapy 2008; 28: 250-258
26. Fong JJ, Sylvia L, Ruthazer R, et al. Predictors of mortality in patients with suspected propofol infusion syndrome. Crit Care Med 2008; 36: 2281-2287
27. Cray SH, Robinson BH, Cox PN. Lactic academia and bradyarrhythmia in a child sedated with propofol. Crit Care Med 1998; 26: 2087-2092
28. Jouven X, Charles MA, Desnos M, et al. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 2001; 104: 756-761
29. Ahlen K, Buckley CJ, Goodale DB, et al. The 'propofol infusion syndrome': the facts, their interpretation and implications for patient care. Eur J Anaesthesiol 2006; 23: 990-998
30. Culp KE, Augoustides JG, Ochroch AE, et al. Clinical management of cardiogenic shock associated with prolonged propofol infusion. Anesth Analg 2004; 99: 221-226
31. Cremer OL, Moons KG, Bouman EA, et al. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet 2001; 357: 117-118
32. Carson SS, Kress JP, Rodgers JE, et al. A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients. Crit Care Med 2006; 34: 1326-1332
33. Precedex [page insert]. Lake Forest, IL: Hospira, Inc. 2008.
34. Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother 2007; 41: 245-254
35. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007; 298: 2644-2653
36. Ruokonen E, Parviainen I, Jakob SM, et al. Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intens Care Med 2009; 35: 282-290
37. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically Ill patients: a randomized trial. JAMA 2009; 301: 489-499
38. Ely EW, Gautum S, Margolin R, et al. The impact of delirium in the intensive care unit on hospital length of stay. Intens Care Med 2001; 27: 1892-1900
39. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004; 291: 1753-1762
40. Micek ST, Anand NJ, Laible BR, et al. Delirium as detected by the CAM-ICU predicts restraint use among mechanically ventilated medical patients. Crit Care Med 2005; 33: 1260-1265
41. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001; 286: 2703-2710
42. Kollef MH, Levy NT, Ahrens TS, et al. The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest 1998; 114: 541-548
43. Brook AD, Ahrens TS, Schaiff R, et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999; 27: 2609-2615
44. Quenot JP, Ladoire S, Devoucoux F, et al. Effect of a nurse-implemented sedation protocol on the incidence of ventilator-associated pneumonia. Crit Care Med 2007; 35: 2031-2036
45. Marshall J, Finn CA, Theodore AC. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med 2008; 36: 427-433
46. Bucknall TK, Manias E, Presneill JJ. A randomized trial of protocol-directed sedation management for mechanical ventilation in as Australian intensive care unit. Crit Care Med 2008; 36: 1444-1450
47. Elliott R, McKinley S, Aitken LM, et al. The effect of an algorithm-based sedation guideline on the duration of mechanical ventilation in as Australian intensive care unit. Intens Care Med 2006; 32: 1506-1514
48. Kress JP, Pohlman AS, O'Connor MF, et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342: 1471-1477
49. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomized controlled trial. Lancet 2008; 371: 126-134
50. Ely EW, Baker AM, Dunagan DP, et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 1996; 335: 1864-1869
51. Kollef MH, Shapiro SD, Silver P, et al. A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit Care Med 1997; 25: 567-574
52. Marelich GP, Murin S, Battistella F, et al. Protocol weaning of mechanical ventilation in medical and surgical patients by respiratory care practitioners and nurses. Chest 2000; 118: 459-467